ENDRA Life Sciences (NDRA) Cost of Revenue (2016 - 2017)
ENDRA Life Sciences (NDRA) posted quarterly Cost of Revenue of $3085.0 for Q4 2017, down 98.69% year-over-year from $235878.0 in Q4 2016, and down 97.39% quarter-over-quarter from $118270.0 in Q3 2017.
ENDRA Life Sciences (NDRA) Cost of Revenue (2016 - 2017) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Cost of Revenue for 2 consecutive years, with $3085.0 the latest figure, recorded in Q4 2017.
- In Q4 2017, Cost of Revenue fell 98.69% year-over-year to $3085.0; the TTM figure through Sep 2018 stood at $3085.0 (down 99.24% YoY), while the FY2017 annual figure was $172782.0, down 26.75% from the prior year.
- Cost of Revenue declined to $3085.0 in Q4 2017 per NDRA's latest filing, from $118270.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $235878.0 in Q4 2016 and bottomed at $3085.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 3.65 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 2.65 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 266.60 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 845.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 2.93 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 437.50 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 389.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 253.28 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 2.62 Bn |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 3,085.00 |
| Dec 31, 2017 | 3,085.00 |
| Sep 30, 2017 | 118,270.00 |
| Sep 30, 2017 | 118,270.00 |
| Jun 30, 2017 | 51,427.00 |
| Jun 30, 2017 | 51,427.00 |
| Dec 31, 2016 | 235,878.00 |
| Dec 31, 2016 | 235,878.00 |